Binding affinity to biotinylated human TNFalpha trimer (77 to 233 residues) expressed in Escherichia coli BL21(DE3) assessed as binding constant (Kon) by SPR analysis
Binding affinity to biotinylated human TNFalpha trimer (77 to 233 residues) expressed in Escherichia coli BL21(DE3) assessed as binding constant (Koff) by SPR analysis
Binding affinity to biotinylated human TNFalpha trimer (77 to 233 residues) expressed in Escherichia coli BL21(DE3) assessed as binding half life by SPR analysis
Antiarthritic activity in DBA/J mouse model of CFA and glucose-6-phosphate isomerase-induced arthritis model assessed as inhibition of paw swelling at 30 to 100 mg/kg, po BID beginning 1 hr prior to GPI immunization and measured on days 13, 15, and 17 after GPI immunization
Drug uptake in DBA/J mouse model of CFA and glucose-6-phosphate isomerase-induced arthritis model at 10 to 100 mg/kg, po BID beginning 1 hr prior to GPI immunization and measured up to day 17 after GPI immunization by HPLC-MS/MS analysis
Cmax in DBA/J mouse model of CFA and glucose-6-phosphate isomerase-induced arthritis model at 10 mg/kg, po BID beginning 1 hr prior to GPI immunization and measured up to day 17 after GPI immunization by HPLC-MS/MS analysis